idarubicin has been researched along with Thymoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McKenzie, IF; Pietersz, GA; Rowland, AJ | 1 |
| Bogdanovski, M; Li, W; Pietersz, GA | 1 |
| McKenzie, IF; Pietersz, GA; Smyth, MJ | 2 |
4 other study(ies) available for idarubicin and Thymoma
| Article | Year |
|---|---|
Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Survival; Drug Synergism; Idarubicin; Immunotoxins; Leukocyte Count; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured | 1994 |
Tumour eradication with high-dose idarubicin-anti-Ly-2.1 with murine tumour necrosis factor-alpha in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, Ly; Drug Synergism; Humans; Idarubicin; Immunoconjugates; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates.
Topics: Adrenergic beta-Antagonists; Animals; Antibodies, Monoclonal; Cell Division; Cyclandelate; Daunorubicin; DNA Replication; Idarubicin; Mandelic Acids; Mice; Mice, Inbred Strains; Perfusion; Prazosin; Thymoma; Thymus Neoplasms | 1987 |
Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Cell Division; Cell Line; Cell Survival; Daunorubicin; Humans; Idarubicin; Immunotherapy; Mice; Mice, Inbred Strains; Thymoma; Thymus Neoplasms | 1988 |